122 related articles for article (PubMed ID: 30501725)
21. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Tsertsvadze T; Mitskevich N; Bilanishvili A; Girdaladze D; Porakishvili N
Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
[TBL] [Abstract][Full Text] [Related]
22. Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.
Miao Y; Fan L; Wu YJ; Xia Y; Qiao C; Wang Y; Wang L; Hong M; Zhu HY; Xu W; Li JY
Oncotarget; 2016 Mar; 7(12):13551-62. PubMed ID: 26910908
[TBL] [Abstract][Full Text] [Related]
23. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
Goldaniga M; Ferrario A; Cortelazzo S; Guffanti A; Pavone E; Ambrosetti A; Marcheselli L; Rossi F; Luminari S; Rossi A; Cro L; Federico M; Lambertenghi Deliliers G; Baldini L
Am J Hematol; 2008 May; 83(5):349-54. PubMed ID: 18186522
[TBL] [Abstract][Full Text] [Related]
24. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.
Dezorella N; Kay S; Baron S; Shapiro M; Porat Z; Deutsch V; Herishanu Y; Katz BZ
Cytometry B Clin Cytom; 2016 May; 90(3):257-66. PubMed ID: 26082241
[TBL] [Abstract][Full Text] [Related]
25. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
[TBL] [Abstract][Full Text] [Related]
27. Study of diagnostic and prognostic parameters (including flow cytometry) in chronic lymphoproliferative disorders: the Indian perspective.
Kumar N; Varma N; Varma S; Malhotra P
Anal Quant Cytol Histol; 2009 Oct; 31(5):296-303. PubMed ID: 20701097
[TBL] [Abstract][Full Text] [Related]
28. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
29. Rapid and simple immunophenotypic characterization of lymphocytes using a new test.
Bellido M; Rubiol E; Ubeda J; Estivill C; López O; Manteiga R; Nomdedéu JF
Haematologica; 1998 Aug; 83(8):681-5. PubMed ID: 9793249
[TBL] [Abstract][Full Text] [Related]
30. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.
Miao Y; Cao L; Sun Q; Li XT; Wang Y; Qiao C; Wang L; Wang R; Qiu HR; Xu W; Li JY; Wu YJ; Fan L
Hematol Oncol; 2018 Feb; 36(1):121-127. PubMed ID: 28752619
[TBL] [Abstract][Full Text] [Related]
31. Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis.
te Raa GD; Fischer K; Verweij W; van Houte AJ; Kater AP; Biesma DH
Clin Chem Lab Med; 2011 Jan; 49(1):115-20. PubMed ID: 21054188
[TBL] [Abstract][Full Text] [Related]
32. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
[TBL] [Abstract][Full Text] [Related]
33. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders.
Kotsianidis I; Nakou E; Spanoudakis E; Bouchliou I; Moustakidis E; Miltiades P; Vadikolia CM; Szydlo R; Karadimitris A; Tsatalas C
Am J Clin Pathol; 2011 Sep; 136(3):400-8. PubMed ID: 21846915
[TBL] [Abstract][Full Text] [Related]
35. SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders.
Kľoc D; Kurhajec S; Huniadi M; Sýkora J; Guman T; Šarišský M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612827
[TBL] [Abstract][Full Text] [Related]
36. Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders.
Yi S; Li Z; Zou D; Xiong W; Li H; Cui R; Li C; Yan Y; Liu W; Lv R; Yu Z; Chen W; Xu Y; An G; Wang H; Ru K; Cheng T; Wang J; Qiu L
Oncotarget; 2018 Jan; 9(3):3353-3364. PubMed ID: 29423051
[TBL] [Abstract][Full Text] [Related]
37. Concordance between flow cytometry CLL scores.
Sorigue M; Raya M; Vergara S; Junca J
Int J Lab Hematol; 2021 Aug; 43(4):743-751. PubMed ID: 33949096
[TBL] [Abstract][Full Text] [Related]
38. The role of CD180 in hematological malignancies and inflammatory disorders.
Edwards K; Lydyard PM; Kulikova N; Tsertsvadze T; Volpi EV; Chiorazzi N; Porakishvili N
Mol Med; 2023 Jul; 29(1):97. PubMed ID: 37460961
[TBL] [Abstract][Full Text] [Related]
39. Discordant frequencies of tissue-resident and circulating CD180-negative B cells in chronic rhinosinusitis.
Miljkovic D; Ou J; Kirana C; Hulse KE; Hauben E; Psaltis A; Wormald PJ; Vreugde S
Int Forum Allergy Rhinol; 2017 Jun; 7(6):609-614. PubMed ID: 28236375
[TBL] [Abstract][Full Text] [Related]
40. Automated quantification of apoptosis in B-cell chronic lymphoproliferative disorders: a prognostic variable obtained with the Cell-Dyn Sapphire (Abbott) automated hematology analyzer.
Fumi M; Martins D; Pancione Y; Sale S; Rocco V
Int J Lab Hematol; 2014 Dec; 36(6):628-35. PubMed ID: 24888697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
